Actemra (Genentech, Inc.)
Welcome to the PulseAid listing for the Actemra drug offered from Genentech, Inc.. This Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | tocilizumab |
| SUBSTANCE NAME: | TOCILIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2013-10-21 |
| END MARKETING DATE: | 0000-00-00 |
Actemra HUMAN PRESCRIPTION DRUG Details:
| Item Description | Actemra from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 180(mg/mL) |
| START MARKETING DATE: | 2013-10-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-138_494568f6-cc02-4df4-8a18-7d910156b178 |
| PRODUCT NDC: | 50242-138 |
| APPLICATION NUMBER: | BLA125472 |
Other TOCILIZUMAB Pharmaceutical Manufacturers / Labelers:
